Introduction
In France, primary care providers (PCP) handle the bulk of hypertension management and account for 94% of all medical consultations related to high blood pressure (BP). In recent years, there has been a great deal of emphasis on the provider-patient relationship 1 and the degree of importance that patients place on personal care. 2 Although there has been extensive study of patients' psychosocial characteristics and the quality of care received, less work has been carried out on physician-related parameters.
The work of Roter et al. has shed some light on the role of gender in this regard. On the basis of analyses of videotape records from a large number of consultations, it was found that patients tend to speak more, disclose more biomedical and psychosocial information, and make more positive statements when speaking with a female physician than with their male counterparts. [3] [4] [5] It has also been shown that female physicians are significantly more likely than their male counterparts to counsel systematically their patients about unhealthy behaviour patterns 6 although in this study, the significance of gender-based differences disappeared (even if the trend remained) when age was taken into account.
It might reasonably be expected that interpersonal factors are especially important in cardiovascular disease because the chronic nature of many such conditions may require regular consultations and, more importantly, because modifying negative behaviour patterns may be one of the priorities in management. To help avoid individual psychosocial variables (among other things) affecting the quality of patient care, attempts have been made to codify the diagnosis of cardiovascular risk. To improve the management of hypertension, numerous guidelines have been developed based on the idea of overall cardiovascular risk (OCVR). At the time of the study, the most widely used system, in France was the Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES) system which was adapted from the World Health Organization (WHO)-International Society of Hypertension guidelines. 7 It has since been replaced by the Haute Autorité de Santé (HAS) system, which was drafted in close accordance to the recommendations of the European Society of Hypertension. 8 In the ANAES system, unweighted cardiovascular risk factors (CVRFs), target organ damage (TOD), and associated cardiovascular conditions (ACCs) are correlated with BP readings (Table 1) to estimate the patient's OCVR, which is then used to help plan a management strategy. Despite widespread dissemination of such guidelines, BP control in hypertensive patients remains insufficient. Indeed, recent evaluations from seven Western countries have shown that BP control defined as lower than 140/90 mm Hg is as low as 20-55% depending on the country. 9 A recent French study found that the proportion of controlled hypertensive patients decreased from 42.9% in a group of patients with low OCVR to 27% for patients in the high or very high OCVR group, implying that doctors were not adequately considering the OCVR. 10 We can see then that on the one hand there are differences between FPCPs and MPCPs in terms of communication to and management of patients and on the other that hypertensive patients, even those at high or very high cardiovascular risk, are not optimally treated. We thus decided to study if there were differences in OCVR assessment depending on PCP gender. If so, communication to physicians could be optimized and management of hypertensive patients improved.
The primary objective of this observational study was therefore to compare how accurately French FPCPs and MPCPs evaluate OCVR in their hypertensive patients. The secondary objective was to compare the diagnostic approaches of FPCPs and MPCPs, including the relative importance that they attach to different CVRFs, how they evaluate OCVR and the number and kind of complementary tests that they order. This article focuses on differences in attitudes and application of the concept of OCVR. Results concerning questions of management will be described in a separate report.
Materials and methods
The study protocol, the information form, the Case Report Form (CRF) and the financial agreement were approved by the French Order of Physicians.
Primary care providers
To obtain a representative population distributed across France, the physicians invited to participate in the study were selected by random sampling of a comprehensive list of PCPs who were asked to answer a series of questions about themselves and their practice, about their attitudes regarding specific CVFRs, and about how they understand and apply the concept of OCVR. Participating physicians were asked to include the first four successive patients fulfilling the inclusion criteria who were seen during the 3-month period of the study.
Patients
Patients with treated or untreated, uncontrolled essential hypertension (systolic BP (SBP) X140 mm Hg and/or diastolic BP (DBP) X90 mm Hg) associated with at least one other ANAESdefined CVFR were included. Patients whose antihypertensive medication had been initiated in the context of a clinical trial and patients suffering from malignant hypertension were excluded. Demographic and relevant clinical data (CVFRs, ACCs, target organ damage (TOD), test results (when available), and current treatment modalities) for each patient were recorded on the basis of a review of their medical records, an interview, and an examination (which included the average BP from the last two of three mercury sphygmomanometer readings taken after 5 min of rest in a sitting or lying down position). TOD included in the ANAES grid are listed in Table 2 .
OCVR
The PCPs were asked to assess spontaneously the patient's OCVR after completing a CRF for each patient included in the study. This 'Perceived OCVR' was a subjective overall impression of the patient's OCVR taking into account background knowledge of the patient. The CRF required infor- Discrepancies in cardiovascular risk evaluation according to physician's gender J-P Baguet et al mation about BP measurement on the day of the visit as well as, if available in the patient's records, patient status for main cardiovascular risks, target organ damage and associated cardiovascular conditions. The PCPs had neither received any specific training on ANAES recommendations before the study, nor were they asked to use a specific method to evaluate this OCVR.
On the basis of the data provided in the CRF, an independent evaluation of each patient's OCVR ('Calculated OCVR') according to ANAES guidelines was made. In the analysis, these two evaluations were compared on a patient-by-patient basis with concordance defined as agreement between the Perceived and the Calculated OCVR evaluations.
Statistical analysis
The characteristics of FPCPs and MPCPs and those of their respective patient populations were compared using a two-tailed w 2 test (a-risk ¼ 5%). The percentages of concordant assessments (perceived vs calculated OCVR) were compared between FPCPs and MPCPs globally and per level of calculated OCVR. The a-risk was in that case adjusted to 1.7% (Bonferroni adjustment for three comparisons, to ensure a global risk of 5%). Finally, multivariate analyses were conducted to investigate the effect of factors that might impact concordance. Physician demographics, patients demographics, duration of hypertension, AHT treatment, number of risk factors, TOD, were introduced in the model and selected in a stepwise manner. Calculated OCVR was considered a candidate factor or used as a stratifying variable.
Results

Physicians
A total of 3542 primary care physicians registered at least one patient. These participating physicians 
Patients
Of the 14 152 patients included in this study, 11 770 were analysed. The reasons for ineligibility were: hypertension having been brought under control or BP readings unavailable (n ¼ 1959), absence of any CVRF (n ¼ 400) and gender of the physician not stipulated (n ¼ 23). Most of the included patients' consultations (79.3%) were specifically for regular hypertension management and the vast majority of patients (97.1%) were already being treated for hypertension at the time of visit. As expected, demographic characteristics were disparate in this highly heterogeneous group of patients although the population tended to be overweight (mean body mass index (BMI) ¼ 27.974.8 kg/m 2 ). The mean age was 63.7711.2 years and there were more men than women (54.1% vs 45.9%). Over half (52.1%) had grade 1 hypertension, 39.8% had grade 2 and 8.1% had grade 3.
Differences between the patients of female and male primary care providers Of the total of 11 770 reports analysed, 1804 (15.3%) were submitted by a FPCP. More than half the reports submitted by FPCPs and less than half of those submitted by MPCPs concerned female patients (53.1 vs 44.6%). No significant differences were detected between the patients of FPCPs and MPCPs with respect to mean values for demographic characteristics (age, mean BP and BMI, Table 2 ) or the length of the history of hypertension. FPCPs were seeing a higher proportion of patients with grade 3 hypertension than their male counterparts (9.4 vs 7.8%; P ¼ 0.02), although no significant difference emerged with respect to the proportions with either grade 1 or 2.
Among the individual risk factors underlying the differential between the patients of FPCPs and MPCPs regarding their calculated cardiovascular risk (Table 2) , there were significant differences for age, smoking and drinking habits but not for other variables measured. Specifically, more of the MPCPs' patients were over the ANAES age threshold (55 for women and 65 for men), and more were smokers and/or regular drinkers.
There were also significant differences for some variables related to TOD (Table 2 ). FPCPs reported a significantly lower prevalence of atheroma and fewer of their patients had protein in their urine. Although TOD data were not missing for more than 20% of patients in any case, some of these may nevertheless have had evidence of TOD, notably protein in the urine, a parameter which the guidelines recommend should be systematically tested. Finally, among the ACCs taken into account in the ANAES system, some significant differences were identified between the patients of FPCPs and those of MPCPs (Table 2) . Finally, when OCVR was calculated (Table 3 ) a lower proportion of the FPCPs' patients was assessed as being at very high risk (26.7 vs 29.2%, P ¼ 0.027) and a higher proportion fell into the medium risk category (26.5 vs 23.2%, P ¼ 0.002). No significant difference emerged with respect to the percentages classified as being at high risk (46.8 vs 47.6%, P ¼ 0.788).
Concordance between 'calculated' cardiovascular risk and the risk as perceived by FPCPs and MPCPs
The PCPs were asked to estimate the OCVR of each of their patients ('Perceived OCVR'). For the 11 659 cases for which a perceived OCVR was available, this classification was compared on a case-by-case Patients for whom no 'Perceived OCVR' estimate is available were omitted from the analysis.
Discrepancies in cardiovascular risk evaluation according to physician's gender J-P Baguet et al basis with the retrospective ANAES-based classification derived from data in the CRF ('Calculated OCVR'). The percentages broken down according to risk category are shown in Table 3 . Although patients at low risk were theoretically excluded from the study (because the inclusion criterion was uncontrolled hypertension with at least one CVRF), some physicians nevertheless assigned patients to this category. Overall concordance between perceived and calculated classifications was 43.5% with no difference between FPCPs and MPCPs (45 vs 43.2%; NS); in fact, no difference was detected between FPCPs and MPCPs in any concordance parameter (including when the data were broken down according to patient gender). When concordance was analysed according to risk category (Table 4) , it was found to be lowest for patients calculated to be at very high risk: only 893 of the 3360 patients (26.6%) in this risk group were correctly evaluated by their physician. More than half (50.9%) of the patients calculated as being at very high risk were slightly under-evaluated as being at high risk, but fully 22.5% were substantially under-evaluated as being at medium risk or even low risk. Patients with a less severe OCVR were better evaluated by both FPCPs and MPCPs, although the tendency towards underevaluation was spread across the spectrum, and the proportion of under-evaluated patients consistently exceeded the proportion that was over-evaluated.
According to logistical model analysis to detect correlations between, on the one hand, the concordance of perceived and calculated OCVR evaluations and, on the other, certain patient characteristics, a set of significant factors emerged (Po0.0001 in every case): women, non-obese subjects, those of over 60, those whose history of hypertension went back less than 5 years, and those at very high as opposed to medium risk according to the calculated OCVR (as well -perhaps unsurprisingly -as those who were on less than two antihypertensive drugs) were all more likely to have been diagnosed 'incorrectly'. Physicians of less than 50 were more likely to make an accurate diagnosis but the physician's gender was not a factor.
Application of the concept of OCVR by FPCPs and MPCPs
Of the 3442 primary care physicians who actively participated in this study, fewer than 10% (8.5 FPCPs vs 10.2% MPCPs; NS) described the concept of OCVR as either irrelevant or without utility. The ANAES system is the most widely used in daily practice in France, especially by FPCPs (56.0 vs 48.4%; Po0.001); Framingham criteria are little used by either FPCPs or MPCPs (5.0 vs 8.6%; P ¼ 0.003), although a small percentage of both claimed that they used more than one evaluation tool (7.8 vs 6.9%, NS). However, fully 42% of all physicians of both genders (39.0 vs 42.6%; NS) used no formal system at all, arriving at their evaluations on an intuitive basis.
Few differences were observed with respect to the relative importance attached to different CVRFs by FPCPs and MPCPs. Diabetes was ranked as the most important CVRF by both FPCPs and MPCPs (27.6 vs 31.6%; P ¼ 0.059). A significantly higher proportion of FPCPs believed abnormal lipid levels to be the most important parameter (25.9 vs 18.1%; Po0.001), whereas a lower proportion ranked smoking as the most important (11.7 vs 15.3%; P ¼ 0.027). No differences emerge for any of the other CVRFs considered. In general, whatever their gender, PCPs tended to attach relatively little importance to isolated high BP readings or, even more markedly, to ACCs, either of which can place a patient in the 'very high risk' category, regardless of any other risk factors.
The mean number of complementary examinations ordered by FPCPs and MPCPs was similar (2.771.5 vs 2.671.5; P ¼ 0.052), but covariate analysis taking age into account revealed a significant gender-based difference (P ¼ 0.032). In particu- 
Discussion
We identified significant differences between the demographic characteristics of FPCPs and those of MPCPs participating in this study: as well as tending to be younger, a higher proportion of the FPCPs qualified relatively recently (notably within the previous 10 years), and more were working in a group practice. Regardless of gender, these factors alone could account for significant differences in attitudes toward OCVR because this concept has only been disseminated among doctors and emphasised in French medical studies since publication of the ANAES recommendations in 1997. However, when it comes to either attitude to the OCVR concept or its application, no significant differences were detected between FPCPs and MPCPs. Of course, in an observational study such as this, it is difficult to rule out the possibility that skewing factors may be interfering with and obscuring gender-based differences. However, covariate analysis taking age into account failed to reveal any evidence of this, and the only significant difference detected between the two subpopulations was that FPCPs tended to order more complementary examinations.
If the relationship between PCP and patient is influenced by the gender of the physician, then the dyad (i.e. the gender of the physician coupled with that of the patient, which generates four possibilities) would also be expected to be an important factor. In this study, although the focus was on the gender of the care provider, no difference in concordance was observed between FPCPs and MPCPs when rates for male and female patients were compared, suggesting that the dyad is not a significant variable with respect to the diagnosis of cardiovascular risk although further, more targeted research would be needed to be able to come to any firm conclusion in this respect.
We need to point out here some study limitations inherent to an observational study. First of all our sample of PCPs did not reflect the national FPCP/ MPCP ratio (15.9% of FPCPs instead of 37%). Second, the percentage of excluded patients is near 17% and could have introduced a selection bias. Finally, it could have been useful to have more details about the number of hypertensive patients managed by each PCP and about the frequency of visits before study inclusion, as these parameters could also have an influence on OCVR perception.
If a codified instrument such as the ANAES grid was strictly applied, physician-based variables, such as gender, should not affect the diagnostic outcome. However, this is not currently the case; fully 42% of the physicians in this study (with no significant difference between FPCPs and MPCPs) claimed that they arrive at their diagnosis on an intuitive basis -even if the majority 'take into account' the concept of OCVR. This is associated with a general tendency to underestimate substantially their patients OCVR if the current recommendations are taken as the frame of reference. Despite this, on the one hand, generalised consensus in the international medical community as to the value of the current guidelines coupled with their widespread dissemination, and on the other the simplicity of the ANAES system (in which each factor is considered as either present or absent and has an identical weighting) as opposed to other risk models such as Framingham 11 and SCORE, 12 in which different CVFRs are assigned 'true' values.
Particularly worrying is that the degree of risk is most commonly underestimated in those patients who are at highest risk, with only just over onequarter of patients in the very high-risk category being thus assigned by their PCP. Aggressive management of BP and other CVRFs is indicated in these patients and may be denied to many of them as a result of underestimated risk. This is particularly true of the 22.5% of patients at very high risk who were diagnosed as being at medium or even low risk. This failure to apply the guidelines for diagnostic procedures with the rigor implicit in their design explains much of the disparity between the recommendations and current performance in hypertension management. Although it is outside the scope of this observational study to provide information about long-term treatment consequences of such an underestimation of OCVR, it would be interesting to make this the purpose of another study. Meanwhile, our findings indicate that more effort should be made to ensure that PCPs in France benefit from specific ANAES guideline training.
What is known about the topic? K The provider-patient interaction is correlated to the trust and compliance with preventive measures and medication K There are differences between male and female primary care providers, especially regarding communication to patients K French doctors do not adequately consider the overall cardiovascular risk during management of hypertensive patients.
What this study adds? K There was no difference between male and female primary care providers regarding attitude to or application of the overall cardiovascular risk concept. K The global cardiovascular risk was underestimated according to the general practitioners 'subjective estimation'.
